BLFS
Price
$24.98
Change
-$1.89 (-7.03%)
Updated
Dec 18 closing price
84 days until earnings call
CHEOY
Price
$92.80
Change
-$3.25 (-3.38%)
Updated
Dec 18 closing price
Ad is loading...

BLFS vs CHEOY

Header iconBLFS vs CHEOY Comparison
Open Charts BLFS vs CHEOYBanner chart's image
BioLife Solutions
Price$24.98
Change-$1.89 (-7.03%)
Volume$376.9K
CapitalizationN/A
CochLear
Price$92.80
Change-$3.25 (-3.38%)
Volume$7.3K
CapitalizationN/A
BLFS vs CHEOY Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHEOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. CHEOY commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a StrongBuy and CHEOY is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BLFS: $24.98 vs. CHEOY: $92.80)
Brand notoriety: BLFS and CHEOY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 90% vs. CHEOY: 71%
Market capitalization -- BLFS: $810.87M vs. CHEOY: $10.47B
BLFS [@Medical Specialties] is valued at $810.87M. CHEOY’s [@Medical Specialties] market capitalization is $10.47B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileCHEOY’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • CHEOY’s FA Score: 1 green, 4 red.
According to our system of comparison, CHEOY is a better buy in the long-term than BLFS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 5 TA indicator(s) are bullish while CHEOY’s TA Score has 3 bullish TA indicator(s).

  • BLFS’s TA Score: 5 bullish, 4 bearish.
  • CHEOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than CHEOY.

Price Growth

BLFS (@Medical Specialties) experienced а -5.09% price change this week, while CHEOY (@Medical Specialties) price change was -1.20% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.50%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +1.07%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Medical Specialties (-4.50% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHEOY($10.5B) has a higher market cap than BLFS($811M). BLFS has higher P/E ratio than CHEOY: BLFS (238.10) vs CHEOY (59.52). BLFS YTD gains are higher at: 53.723 vs. CHEOY (-6.571). CHEOY has higher annual earnings (EBITDA): 434M vs. BLFS (-45.24M). CHEOY has higher revenues than BLFS: CHEOY (1.71B) vs BLFS (143M).
BLFSCHEOYBLFS / CHEOY
Capitalization811M10.5B8%
EBITDA-45.24M434M-10%
Gain YTD53.723-6.571-818%
P/E Ratio238.1059.52400%
Revenue143M1.71B8%
Total Cash51.7MN/A-
Total Debt42.7MN/A-
FUNDAMENTALS RATINGS
BLFS vs CHEOY: Fundamental Ratings
BLFS
CHEOY
OUTLOOK RATING
1..100
8183
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
7950
SMR RATING
1..100
9557
PRICE GROWTH RATING
1..100
3858
P/E GROWTH RATING
1..100
1475
SEASONALITY SCORE
1..100
2n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHEOY's Valuation (12) in the null industry is significantly better than the same rating for BLFS (95) in the Medical Specialties industry. This means that CHEOY’s stock grew significantly faster than BLFS’s over the last 12 months.

CHEOY's Profit vs Risk Rating (50) in the null industry is in the same range as BLFS (79) in the Medical Specialties industry. This means that CHEOY’s stock grew similarly to BLFS’s over the last 12 months.

CHEOY's SMR Rating (57) in the null industry is somewhat better than the same rating for BLFS (95) in the Medical Specialties industry. This means that CHEOY’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's Price Growth Rating (38) in the Medical Specialties industry is in the same range as CHEOY (58) in the null industry. This means that BLFS’s stock grew similarly to CHEOY’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for CHEOY (75) in the null industry. This means that BLFS’s stock grew somewhat faster than CHEOY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSCHEOY
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
60%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
49%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
51%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 8 days ago
64%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
69%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHEOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with AZTA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-7.03%
AZTA - BLFS
52%
Loosely correlated
+7.21%
MASS - BLFS
50%
Loosely correlated
-7.39%
RGEN - BLFS
49%
Loosely correlated
-6.83%
VCYT - BLFS
48%
Loosely correlated
-6.42%
TMO - BLFS
43%
Loosely correlated
-2.39%
More

CHEOY and

Correlation & Price change

A.I.dvisor tells us that CHEOY and TWST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHEOY and TWST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEOY
1D Price
Change %
CHEOY100%
-3.38%
TWST - CHEOY
29%
Poorly correlated
-7.83%
SKHHY - CHEOY
28%
Poorly correlated
-4.00%
BLFS - CHEOY
26%
Poorly correlated
-7.03%
TMO - CHEOY
25%
Poorly correlated
-2.39%
ESTA - CHEOY
25%
Poorly correlated
-4.95%
More